Verified Market Research® a leading provider of business intelligence and market analysis is thrilled to announce the release of its comprehensive and authoritative report on the, "Cell Counting ...

Detroit, Michigan--(Newsfile Corp. - December 8, 2025) - Artificial Intelligence Technology Solutions, Inc. (OTCID: AITX) (the "Company") , a global leader in AI-driven security and productivity ...

Some batteries that power a popular brand of e-bike pose a fire hazard that can cause serious injury or death and shouldn't be used, the Consumer Product Safety Commission (CPSC) said in a notice ...

The batteries that power Rad Power Bikes’ e-bikes “pose a risk of serious injury and death” and owners should stop using them, according to the U.S. Consumer Product Safety Commission (CPSC). The ...

Third Arc Bio is paying $5 million upfront to use Adagene’s tech in hopes of creating two new masked T-cell engagers. Down the line, Adagene could make up to $840 million in development and commercial ...

The market didn't react positively to the diagnostics specialist's third-quarter earnings report. It beat on both the top and bottom lines, but growth rates were low. Bio-Rad's Q3 saw the company book ...

The new ingredient is positioned as an ‘insurance policy’ against cocoa supply chain volatility and says the bio-identical ingredient could stabilize supply as climate change strains traditional crops ...

HERCULES, Calif.--(BUSINESS WIRE)-- Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, today announced that Alice N. Schwartz ...

Jason Mast is a general assignment reporter at STAT focused on the science behind new medicines and the systems and people that decide whether that science ever reaches patients. You can reach Jason ...

Fluidic Sciences Ltd, a leader in in‑solution protein interaction analysis, today announced it has purchased the business and assets of Sphere Bio Ltd. The transaction creates a powerful, ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min T-cell immunotherapy company ...

10x Genomics is stepping up to buy Scale Biosciences and its single-cell profiling solutions, with plans to implement them within the company’s Chromium platform. The deal for the recent Fierce ...